Keyphrases
Germ Cells
100%
Melanoma
66%
Cancer Predisposition Genes
41%
Clinical Features
33%
Atrial Fibrillation
33%
Merkel Cell Carcinoma
33%
Dermal Sarcoma
33%
Systemic Treatment
33%
Gene Panel Sequencing
33%
Immunological Characteristics
33%
Somatic Testing
33%
CHA2DS2-VASc Score
33%
Germline Pathogenic Variant
33%
Cancer Predisposition
33%
Astronaut
33%
Radiation-induced Heart Disease
33%
Cancer Susceptibility
33%
Odyssey
33%
B-cell Malignancies
33%
Bruton Tyrosine Kinase Inhibitor
33%
Commercially Available
25%
Systemic Therapy
16%
Germline Variants
16%
Germline Gene
16%
Hereditary Cancer
16%
Gene number
16%
Germline Predisposition
15%
Oncologic
15%
Free Survival
13%
Net Reclassification Index
13%
Akaike Information Criterion
13%
Stroke Risk
13%
Adverse Events
13%
Patients with Cancer
8%
Ongoing Clinical Trials
8%
Treatment Regimen
8%
Progression-free Survival
8%
Disease Control
8%
Immune System
8%
Improved Outcomes
8%
Overall Survival
8%
Immune Checkpoint Inhibitors
8%
Response Rate
8%
Syndrome-based
8%
Germline Findings
8%
Incidental
8%
Chemotherapy
8%
Targeted Agents
8%
Test Guideline
8%
Durable Response
8%
Medicine and Dentistry
Germ Cell
66%
Melanoma
66%
Malignant Neoplasm
50%
Cancer
41%
Systemic Therapy
33%
Merkel Cell Carcinoma
33%
B Cell
33%
Connective Tissue Cancer
33%
Atrial Fibrillation
33%
Cancer Susceptibility
33%
Systematic Review
33%
Cardiovascular Disease
33%
Apoplexy
33%
Bruton Tyrosine Kinase Inhibitor
33%
Adverse Event
20%
Diseases
16%
Clinical Trial
15%
Cardiovascular System
13%
CHA2DS2-VASc Score
12%
Disease Predisposition
8%
Immune Checkpoint Inhibitor
8%
Immune System
8%
Neoplasm
8%
Population Research
8%
Progression Free Survival
8%
Overall Survival
8%
Chemotherapy
8%
Radiation Exposure
8%
Dermatological Agent
6%
Non-Hodgkin Lymphoma
6%
Monotherapy
6%
Gastrointestinal Distress
6%
Retrospective Study
6%
Akaike Information Criterion
6%
Proportional Hazards Model
6%
Cutaneous Melanoma
5%
Granulocyte
5%
Biochemistry, Genetics and Molecular Biology
Germ Cell
100%
Germline
100%
Tyrosine Kinase Inhibitor
33%
Atrial Fibrillation
33%
Next Generation Sequencing
33%
B Cell
33%
Bruton Tyrosine Kinase
33%
Clinical Trial
6%
Colon
6%
Retrospective Study
6%
Gene Linkage
6%
BRIP1
5%
BAP1
5%
BRCA2
5%
PMS2
5%
Microphthalmia-Associated Transcription Factor
5%
MLH1
5%
MSH2
5%
RAD51C
5%
CHEK2
5%
Twin Study
5%
Polymorphonuclear Cell
5%